Bio-Medical Applications Of Alabama, Inc. in Anniston, Alabama - Dialysis Center

Bio-Medical Applications Of Alabama, Inc. is a medicare approved dialysis facility center in Anniston, Alabama and it has 10 dialysis stations. It is located in Calhoun county at 2017 Quintard Ave, Suite B, Anniston, AL, 36201. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc. at (256) 235-2452. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc. has the following ownership type - Profit. It was first certified by medicare in December, 2015. The medicare id for this facility is 012682 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Alabama, Inc.
Location	2017 Quintard Ave, Suite B, Anniston, Alabama
No. of Dialysis Stations	10
Medicare ID	012682
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Alabama, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1679951974
Organization Name	Fresenius Medical Care Anniston North
Doing Business As	Bio-medical Applications Of Alabama, Inc.
Address	2017 Quintard Ave Anniston, Alabama, 36201
Phone Number	(256) 235-2925

Dialysis patients with Hemoglobin data	11
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	9

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	23
  Adult patient months included in Kt/V greater than or equal to 1.2	229
  Percentage of adult patients getting regular hemodialysis at the center	99
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc. with elevated calcium levels.

Patients with hypercalcemia	23
Hypercalcemia patient months	229
Patients with Serumphosphor	23
Patients with Serumphosphor less than 3.5 mg/dL	13
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	20
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	26
Patients with Serumphosphor from 5.6 to 7 mg/dL	24
Patients with Serumphosphor greater than 7 mg/dL	16

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	20
Patient months included in arterial venous fistula and catheter summaries	170
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	49
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	2

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	17
Hospitalization Rate in facility	269.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit	669
Hospitalization Rate: Lower Confidence Limit	116.7

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	15 (As Expected)
Readmission Rate: Upper Confidence Limit	33.5
Readmission Rate: Lower Confidence Limit	4.5